Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
OPRX | US
0.43
8.69%
Technology
Health Information Services
30/06/2024
04/06/2026
5.38
5.06
5.61
4.96
OptimizeRx Corporation a digital health technology company provides various solutions to life sciences organizations healthcare providers (HCPs) and patients. Its products and applications include Evidence-Based Physician Engagement solution to assist HCPs in identifying patients who may be qualified for specific therapies raise awareness of patient access pathways and identify early indicators of non-adherence among patient populations; and Point of Care Banner messaging solution to deliver a variety of awareness and messaging within the clinical workflow. The company also offers Social Network Banner Messaging solution to deliver banner messaging to HCPs within their social network apps; Institutional Account-based Banner Messaging solution that provides its clients access to delivering banner messaging online and on the intranets of targeted health system accounts; and Financial Messaging solution which provides prescribers visibility to branded copay offers and other patient support programs directly within their electronic health record and/or e-Prescribe systems. In addition it provides Patient Engagement a technology solution that provides digital messaging services through its cloud-based Mobile Health Messenger platform; HIPAA-compliant automated mobile messaging platform which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance; and Therapy Initiation Workflow a group of digital solutions that focuses on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was founded in 2006 and is headquartered in Rochester Michigan.
View LessValue Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
65.6%1 month
95.3%3 months
81.9%6 months
73.9%-
13.70
1.02
0.30
0.21
-16.77
1.73
1.61
-6.62M
98.57M
98.57M
-
-19.93
-66.80
36.10
-15.13
7.97
4.79
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.82
Range1M
2.32
Range3M
3.68
Rel. volume
0.89
Price X volume
2.56M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Common Stock | BNGO | Diagnostics & Research | 1.26 | 108.36M | -3.08% | 0.03 | 34.32% |
| Definitive Healthcare Corp. | DH | Health Information Services | 0.9073 | 106.27M | 3.36% | n/a | 40.35% |
| Medical Outcomes Research Analysis LLC | FORA | Health Information Services | 2.83 | 88.04M | 70.33 | 85.89% | |
| ENDRA Life Sciences Inc | NDRA | Diagnostics & Research | 4.77 | 87.72M | 0.85% | n/a | 3.13% |
| Anixa Biosciences Inc | ANIX | Diagnostics & Research | 2.62 | 84.31M | 3.97% | n/a | 1.09% |
| Sera Prognostics Inc. | SERA | Diagnostics & Research | 2.245 | 74.91M | 9.51% | n/a | 2.27% |
| The InterGroup Corporation | INTG | Real Estate Services | 33.5 | 73.00M | -8.69% | n/a | -238.17% |
| Neuronetics Inc | STIM | Diagnostics & Research | 1.46 | 44.24M | 5.04% | n/a | 323.03% |
| CCLD | CCLD | Health Information Services | 2.4 | 40.59M | 2.13% | n/a | 20.40% |
| STAR EQUITY HOLDINGS INC | STRR | Diagnostics & Research | 11.65 | 37.53M | 0.87% | n/a | 26.85% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| White Energy Company Limited | WECFF | Coal | 0.1432 | 28.49M | n/a | -2054.06% | |
| Tantech Holdings Ltd | TANH | Coal | 0.4251 | 3.55M | -5.18% | 0.09 | 6.96% |
| Watford Holdings Ltd | WTRE | Insurance - Diversified | 26.577 | 0 | 1.30% | n/a |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -16.77 | 15.88 | Cheaper |
| Ent. to Revenue | 1.73 | 14.90 | Cheaper |
| PE Ratio | - | 64.03 | - |
| Price to Book | 1.02 | 6.17 | Cheaper |
| Dividend Yield | - | 1.35 | - |
| Std. Deviation (3M) | 81.87 | 64.72 | Riskier |
| Debt to Equity | 0.30 | 0.44 | Cheaper |
| Debt to Assets | 0.21 | 0.35 | Cheaper |
| Market Cap | 98.57M | 3.23B | Emerging |